NASDAQ
SLBT
Last Price
US $2.71
Valuation
Financial
Performance
Cash flow to debt coverage
SL Science Holding Ltd cash flow to debt ratio of -894.92% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
SL Science Holding Ltd's free cash flow has decreased 919.10% from $272.19K last year to $-2.23M, signaling decreasing performance
Debt-to-equity ratio
SL Science Holding Ltd's debt to equity ratio is 0.09, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
SL Science Holding Ltd has insufficient data to evaluate this check.
Net debt to EBITDA
SL Science Holding Ltd has a net cash position, so leverage is healthy.
Interest coverage
SL Science Holding Ltd earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
SL Science Holding Ltd's profit margin has decreased (390.83%) in the last year from -35.42% to -173.85%, signaling decreasing performance
Current ratio
SL Science Holding Ltd's short-term assets of $1.43M exceed its short-term liabilities of $468.54K
Return on assets
SL Science Holding Ltd's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
SL Science Holding Ltd's return on equity of -95.36%, is lower than 15.00%, indicating bad performance
Earnings quality
SL Science Holding Ltd's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
SL Science Holding Ltd has insufficient public price history to evaluate earnings stability.
Positive free cash flow
SL Science Holding Ltd has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
SL Science Holding Ltd has negative free cash flow, indicating cash burn
Earnings growth
SL Science Holding Ltd's yearly earnings has decreased 220.63% since last year from $-1.19M to $-3.82M, signaling decreasing performance
Revenue growth
SL Science Holding Ltd's yearly revenue has decreased 34.68% since last year from $3.36M to $2.20M, signaling decreasing performance
Return on invested capital
ROIC -153.66% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
SL Science Holding Ltd has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
SL Science Holding Ltd has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
SL Science Holding Ltd has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
SL Science Holding Ltd has insufficient data to evaluate this check.
Earnings yield (TTM)
SL Science Holding Ltd has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
SL Science Holding Ltd is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
SL Science Holding Ltd has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
SL Science Holding Ltd has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
SL Science Holding Ltd has negative shareholder equity; price-to-book is not meaningful and the check fails
Price-to-sales ratio (TTM)
SL Science Holding Ltd has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-95.36%
Return on equity
ROIC: -153.66%
Valuation History
-
Price to Earnings
EV/EBITDA: -405.6X
Cash flow
Profit margin
-
Fair Value
Market $2.71
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.